Skip to main content
Clinical Trials/DRKS00016157
DRKS00016157
Completed
Not Applicable

Sex- and Gender-sensitive prevention of cardiovascular and metabolic disease in older adults in Germany - GendAge

Charité Campus Virchow-Klinikum0 sites1,100 target enrollmentApril 3, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The GendAge study explores mechanisms of disease development with respect to sex differences and considers socio-cultural factors.The study focuses on cardio-metabolic disease.As part of the GendAge study, a follow-up medical examination of the older sub-population of the Berlin Aging Study (BASE-II) is conducted.BASE-II studies physical, psychological and social factors, which impact healthy aging.
Sponsor
Charité Campus Virchow-Klinikum
Enrollment
1100
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2019
End Date
March 10, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Charité Campus Virchow-Klinikum

Eligibility Criteria

Inclusion Criteria

  • Participants were eligible for inclusion in the GendAge cohort, if they had taken part in the first\-wave study (BASE II), belonged to the older age\-group of BASE II (N\=1600, mean age 68,2 ±3,7 years) and provided written informed consent. The BASE II is a classic convenience sample of 60 to 80 year olds (older age group, baseline), drawn from the Berlin metropolitan area.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials